As the clinical landscape evolves, healthcare professionals are constantly navigating more complex data, and putting a greater demand on medical affairs for more scientific exchange.
The increasing visibility not only puts additional pressure on medical teams to be operationally effective but also to better demonstrate outcomes.
In this episode of Veeva’s podcast series, “What Pharma Needs Next”, Christoph Bug, VP Global Medical at Veeva, speaks to several industry experts about the ongoing transformation of medical affairs to become a more strategic, data-driven decision-making organization.
Learn more about measuring medical impact.